No Data
The physician-led phase 1 trial of Nano mRNA---3Q TUG1 ASO (glioblastoma) is proceeding smoothly.
On the 14th, NANO MRNA (4571) announced its consolidated financial results for the third quarter of the fiscal year ending March 2025 (April-December 2024). Revenue was 0.083 billion yen, a 20.3% decrease compared to the same period last year, operating loss was 0.485 billion yen (compared to a loss of 0.687 billion yen in the same period last year), recurring loss was 0.446 billion yen (compared to a loss of 0.663 billion yen in the same period last year), and net loss attributable to shareholders of the parent company was 0.595 billion yen (compared to a loss of 0.737 billion yen in the same period last year). Regarding the main research and development progress during the cumulative period of the third quarter, TUG1
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks that have shifted to Buy Market Code Stock Name Closing Price SAR Main Board <2060> Feed One 809 768 <2587> Suntory BF 49374521 <2749> JPHD 605515 <2897> Nissin Food HD 31002911 <2982> AD Works Group 229219 <3093> Trade Factory 15201455 <3221> Yoshix 28512759 <3
Petroleum resources, light industry, etc. (additional) Rating
Upgraded - Bullish Code Stock Name Brokerage Firm Previous Changed After-------------------------------------------------------------<268A> Rigaku Nomura "Hold" "Buy" <3626> TIS GS "Hold" "Buy" <4528> Ono Pharmaceutical City "3" "2" <6752> Panasonic HD Morgan Stanley "Equal Weight" "Over Weight" <7735> Screen Morgan Stanley "Equal Weight" "Over Weight"
Rating information (Target Price change - Part 1) = Nisshin Oil, Oji Holdings, ETC.
◎ Nomura Securities (three-stage: Buy > Neutral > Reduce) Nichiyo <4403.T> -- "Buy" → "Buy", 2,880 yen → 2,960 yen M&A Cap <6080.T> -- "Buy" → "Buy", 4,400 yen → 4,500 yen SMC <6273.T> -- "Buy" → "Buy", 95,000 yen → 80,000 yen CKD <6407.T> -- "Buy" → "Buy", 4,000 yen → 3,400 yen Yokogawa Electric <6841.T> -- "Buy" → "Buy",
Oasis: Nominated Yannis Skoufalos, Martha Velando, Lanchi Venator, Hugh Dineen, Anja Lagodny >4452.TO
Oasis Management: Proposes Five Bd Director Nominees to Set Kao on a 'Path to Becoming a Global Leader'